Literature DB >> 12727293

Roles of mu-calpain in cultured L8 muscle cells: application of a skeletal muscle-specific gene expression system.

Ying-yi Xiao1, Mei-Chuan Wang, Juntipa Purintrapiban, Neil E Forsberg.   

Abstract

The goal of this work was to characterize the roles of mu-calpain in skeletal muscle protein degradation. Three approaches were developed to alter mu-calpain activity in rat myotubes. These included over-expression of antisense mu-calpain (mu-AS), dominant negative mu-calpain (mu-DN) and the antisense 30-kDa calpain subunit (30-AS). Constructs were expressed in rat L8 myotubes, and their effects on protein degradation and on concentrations of intact and/or degraded fodrin, desmin and tropomyosin were examined. An ecdysone-inducible expression system, in which we replaced a constitutively active CMV promoter with a skeletal muscle-specific alpha-actin promoter, was used to drive expression. Cell lines were evaluated by expression of the gene-of-interest following addition of ponasterone A (PA; ecdysone analog) to culture medium. Changes in calpain activity were assessed by evaluating fodrin degradation. 30-AS, which should alter both mu- and m-calpain activities, increased intact fodrin concentration. mu-DN and mu-AS reduced fodrin degradation products. mu-DN reduced total protein degradation by 7.9% (P<0.01) at 24 h and by 10.6% (P<0.01) at 48 h. mu-AS reduced total protein degradation by 6.4% at 24 h (P<0.05). 30-AS reduced total protein degradation by 13.4% (P<0.05) and 7.3% (P<0.05) following 24 and 48 h of PA administration, respectively. We assessed effects of mu-DN, mu-AS and 30-AS on concentrations of desmin and tropomyosin. Inhibition of calpains stabilized desmin, but had no effect on tropomyosin. These data indicate that fodrin and desmin are mu-calpain substrates and that mu-calpain accounts for a small proportion of total protein degradation in muscle cells. Tropomyosin is not degraded by calpain in muscle cells.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12727293     DOI: 10.1016/s1532-0456(03)00026-7

Source DB:  PubMed          Journal:  Comp Biochem Physiol C Toxicol Pharmacol        ISSN: 1532-0456            Impact factor:   3.228


  3 in total

1.  Expression of atrophy mRNA relates to tendon tear size in supraspinatus muscle.

Authors:  Silvia Schmutz; Thomas Fuchs; Felix Regenfelder; Patrick Steinmann; M Zumstein; Bruno Fuchs
Journal:  Clin Orthop Relat Res       Date:  2008-10-22       Impact factor: 4.176

2.  Repairing process in the transected muscle fibers of the mouse tibialis anterior.

Authors:  Michiko Matsumoto; Takako Matsubara; Akinori Miki
Journal:  J Jpn Phys Ther Assoc       Date:  2007

3.  Early dystrophin loss is coincident with the transition of compensated cardiac hypertrophy to heart failure.

Authors:  Fernanda P Prado; Daniele O Dos Santos; Valdecir Blefari; Carlos A Silva; Juliano Machado; Isis do Carmo Kettelhut; Simone G Ramos; Marcelo Dias Baruffi; Helio C Salgado; Cibele M Prado
Journal:  PLoS One       Date:  2017-12-21       Impact factor: 3.240

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.